Pharmaciana

Vol.x, No.x, Bulan 201x, Hal. xx-xx

ISSN: 2088 4559; e-ISSN: 2477 0256
DOI: 10.12928/pharmaciana.xxxx.xxxx 1

Write the title which reflecting the work and result of the research
(maximum 15 words, center, bold, 14pt)

Author1, Author 2, Author 3 (12pt)

Note: Mark *) after the name, if it is the corresponding author
1
affiliation of main author and address (11pt)
2
affiliation of second author and address (11pt)

Submitted :........................ Reviewed :.......................... Accepted:.....................

ABSTRACT (11pt, spasi 1)

Write abstract which is a summary of the article. Abstract is created in one paragraph and a
maximum of 300 words. In the abstract should contain the background, objectives, methodology,
results, and conclusions, but not necessarily explicit words. Abstract should not contain tables /
images and citation. The use of abbreviations should be a minimum
.
Keywords: provide 3-6 keywords

Corresponding author:
Name,
Affiliation of author,
Address.
Email:

INTRODUCTION (11pt)
The manuscript is written in English with Times New Roman, 1 (one) column, 1 spacing,
on A4 paper. Authors are asked to send in the form of files typed with MS-Word program and
submitted via OJS by address: http://journal.uad.ac.id/index.php/PHARMACIANA.
The number of paragraphs is not limited but should include background, research
objectives, research positions on previous research and novelty. A few theoretical foundations that
are directly related to the content of articles can be included. It is no necessary to create a title (sub
chapters) in the introduction.

MATERIALS AND METHOD (11pt)

Materials
List the major tools or specific tools used in the study including the brand, type, and
specifications. The tools which commonly used in laboratory such as glassware, napkins, scalpels,
etc., should not be included. Specific such as self-designed tools, or modifications should be
shown the schematic / drawing / photograph. The genes, strains, age, and average body weight of

Journal homepage: http://journal.uad.ac.id/index.php/PHARMACIANA

2 ISSN: 2088 4559; e-ISSN: 2477 0256
the test animals should be reported in this section.The plant samples should be mentioned the
origin and its authentication.

Methods
Only new techniques need to be described in detail for reproducibility. Known or
published methods must have adequate reference. Relevant modifications should be described.
The long research steps can be made in sub chapters of research stages with Arabic
numbering.
1. First step
Describe the research step briefly but clearly. Mention the adequate reference.
2. Second step etc

Data Analysis
Describe the analysis methode clearly.

Result and Discussion (11pt)

Result and discussion should be combined in the manuscript. It is should be described concisely.
Text, tables and figures must be internally consistent. Discussion should involve the significant
findings presented with relevant and extensive discussion.

Table I. The tittle of table should be placed on the top-center? of table. The tittle should be clear and reflect

the result

Groups Percentage of result % ± SD or SE

Normal 6,12 ± 0,99
DMBA 33,66 ± 6,23
DMBA+Doxorubisin 15,44 ± 2,23
DMBA+EEAPB 12,95 ± 2,40
DMBA+Doxorubisin+EEAPB 17,71 ± 1,33

(A) (B)

Figure 1. The tittle of figure should be placed on the bottom of figure. The tittle should be
clear and reflect the result presented in the figure (A) xxxxxx (B)xxxxxx

CONCLUSION (11pt)
The conclusion is made one paragraph, without any citation.

ACKNOWLEDGEMENT (11pt)
The authors may acknowledge people, organizations, and financing/funding (you may state
grant numbers and sponsors here ).

Pharmaciana Vol. x, No. x, Bulan 201x, Hal. xx – xx

3Pharmaciana ISSN: 2088 4559; e-ISSN: 2477 0256

REFERENCES (11pt)
Please use the reference manager for this section. Please write reference in the text using Harvard
format, for journal (Nurkhasanah et al., 2015), book (Baratawijaya, 2001). etc

List in the reference

Baratawijaya, 2001, Imunologi Dasar. Jakarta: Fakultas Kedokteran Universitas Indonesia.

Nurkhasanah, Trisnamurti, K. C., Gunaryanti, R. D. and Widyastuti, T., 2015, The Screening of
Cytotoxic Fraction from Elephantopus scaber Linn against Human Cervical Cancer (Hela)
Cells, International Journal of Pharma Sciences and Research, 6(6): 1011–1014.

Judul manuskrip (Penulis pertama)

4 ISSN: 2088 4559; e-ISSN: 2477 0256

Pharmaciana Vol. x, No. x, Bulan 201x, Hal. xx – xx